Back to today’s briefing

Story perspectives

Colossal Biosciences Raises $200M to Revive Extinct Species

1/16/2025

23 4

Summary

Story summary

Colossal Biosciences, a trailblazing Texas startup, has secured $200 million in Series C funding, catapulting its valuation to an impressive $10.2 billion. Founded in 2021, the company is on a mission to bring back extinct species like the woolly mammoth and dodo through cutting-edge genetic engineering. With a total of $435 million raised, Colossal is set to enhance its innovative technologies for conservation and health.

1 of 1

Story summary

Colossal Biosciences, a trailblazing Texas startup, has secured $200 million in Series C funding, catapulting its valuation to an impressive $10.2 billion. Founded in 2021, the company is on a mission to bring back extinct species like the woolly mammoth and dodo through cutting-edge genetic engineering. With a total of $435 million raised, Colossal is set to enhance its innovative technologies for conservation and health.